Immune Checkpoint Inhibitor Therapy- Induced Endocrinopathy
Condition(s):EndocrinopathyLast Updated:September 6, 2019Recruiting
Hide Studies Not Open or Pending
Condition(s):EndocrinopathyLast Updated:September 6, 2019Recruiting
Condition(s):Endocrine DiseaseLast Updated:September 11, 2023Recruiting
Condition(s):Endocrine DiseaseLast Updated:September 17, 2019Recruiting
Condition(s):Gynecomastia; Endocrine System DiseasesLast Updated:November 1, 2021Recruiting
Condition(s):Pituitary ACTH Hypersecretion; Acromegaly; Diabetes Mellitus, Type 1; Primary HyperparathyroidismLast Updated:August 11, 2022Completed
Condition(s):Endocrine DisorderLast Updated:February 23, 2023Suspended
Condition(s):Endocrine DiseasesLast Updated:September 13, 2023Recruiting
Condition(s):Endocrine System DiseasesLast Updated:August 14, 2020Unknown status
Condition(s):Endocrine DiseasesLast Updated:October 6, 2017Terminated
Condition(s):Pregnancy-related ComplicationsLast Updated:April 20, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.